throbber
Biochemistry 2000, 39, 575-583
`
`575
`
`Aggregation Events Occur Prior to Stable Intermediate Formation during Refolding
`of Interleukin 1(cid:226)†
`
`John M. Finke, Melinda Roy, Bruno H. Zimm, and Patricia A. Jennings*
`Department of Chemistry and Biochemistry, UniVersity of California, San Diego, La Jolla, California 92093-0359
`ReceiVed July 1, 1999; ReVised Manuscript ReceiVed October 26, 1999
`
`ABSTRACT: A point mutation, lysine 97 f isoleucine (K97I), in a surface loop in the (cid:226)-sheet protein
`interleukin 1(cid:226) (IL-1(cid:226)), exhibits increased levels of inclusion body (IB) formation relative to the wild-
`type protein (WT) when expressed in Escherichia coli. Despite the common observation that less stable
`proteins are often found in IBs, K97I is more stable than WT. We examined the folding pathway of the
`mutant and wild-type proteins at pH 6.5 and 25 (cid:176) C with manual-mixing and stopped-flow optical
`spectroscopy to determine whether changes in the properties of transiently populated species in vitro
`correlate with the observation of increased aggregation in vivo. The refolding reactions of the WT and
`K97I proteins are both described by three exponential processes. Two exponential processes characterize
`fast events (0.1-1.0 s) in folding while the third exponential process correlates with a slow (70 s) single
`pathway to and from the native state. The K97I replacement affects the earlier steps in the refolding
`pathway. Aggregation, absent in the WT refolding reaction, occurs in K97I above a critical protein
`concentration of 18 (cid:237)M. This observation is consistent with an initial nucleation step mediating protein
`aggregation. Stopped-flow kinetic studies of the K97I aggregation process demonstrate that K97I aggregates
`most rapidly during the earliest refolding times, when unfolded protein conformers remain highly populated
`and the concentration of folding intermediates is low. Folding and aggregation studies together support
`a model in which the formation of stable folding intermediates afford protection against further K97I
`aggregation.
`
`Understanding the factors responsible for the aggregation
`of expressed proteins is a problem of importance not only
`in biotechnology but also in the health-related industries.
`Deposition of insoluble protein aggregates results in the
`formation of inclusion bodies during the bacterial expression
`of recombinant proteins (3-8) as well as a variety of
`pathological conditions in mammals, including Alzheimer’s
`and other amyloid-related disease states (3, 9-12). A
`common characteristic of protein deposition diseases, as well
`as inclusion body formation during bacterial expression, is
`the sensitivity of the extent of aggregation to point mutations
`in the protein of interest (3, 4, 11, 13). The common belief
`is that single amino acid replacements creating off-pathway
`association events are mediated either by intermediates or
`by native states, as a single mutation is thought to be unlikely
`to be able to alter significantly the unfolded biopolymer (14).
`However, it is known that mutations can and do affect the
`stability and transient structure of the unfolded state (15).
`Thus, the effects of point mutations on aggregation formed
`during protein folding may help identify the species and
`factors involved in protein deposition.
`To address fully protein aggregation phenomena, detailed
`structural and biochemical information on the protein being
`
`† This work supported by Hellman Faculty Fellowship (P.A.J.), Sloan
`Fellowship (P.A.J.), NIH Grant GM54038 (P.A.J.), and Public Health
`Service Grant CA09523 (J.M.F. and M.R.).
`* To whom correspondence should be addressed: University of
`California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0359.
`Phone (858) 534-6417; Fax (858) 534-6714; Email pajennin@ucsd.edu.
`
`studied must be available in addition to a consistent method
`of modulating aggregation. Consequently, recombinant hu-
`man interleukin 1(cid:226) (IL-1(cid:226))1 is an excellent model system
`for characterizing the effects of point mutations on the
`competition between on-pathway folding events and off-
`pathway aggregation. The wild-type protein (WT) is found
`predominantly (>90%) in the soluble fraction of whole-cell
`lysates when expressed at 37 (cid:176) C in Escherichia coli, and a
`number of point mutations have been identified that show
`dramatic effects on the levels of inclusion bodies formed
`(>90% insoluble) (4, 16, 17). Of particular interest is the
`mutation in the surface loop 86-99 that replaces the
`positively charged lysine side chain at position 97 with the
`hydrophobic side chain of isoleucine (18; see Figure 1 and
`Materials and Methods). This mutation K97I results in a
`native state that is thermodynamically more stable than the
`wild-type protein yet is found predominantly in inclusion
`bodies when expressed at 37 (cid:176) C in E. coli. No alteration in
`the kinetics of the slow step in folding, nor the ribosomal
`synthesis rates, nor protein-chaperone interactions have been
`found with this mutation (17). FTIR analysis indicates that
`
`1 Abbreviations: FTIR, Fourier transform infrared spectroscopy;
`IPTG, isopropyl (cid:226)-D-thiogalactopyranoside; PMSF, phenylmethane-
`sulfonyl fluoride; EDTA, ethylenediaminetetraacetic acid; DTT, dithio-
`threitol; (cid:226)me, 2-mercaptoethanol; Tris-HCl,
`tris(hydroxymethyl)-
`aminomethane hydrochloride; MES, 2-(4-morpholino)ethanesulfonic
`acid; GdnHCl, guanidine hydrochloride; Gdn-SCN, guanidine thiocy-
`anate; FPLC, fast protein liquid chromatography; SDS-PAGE, sodium
`dodecyl sulfate-polyacrylamide gel electrophoresis; ESI-MS, electro-
`spray ionization mass spectrometry; IL-1(cid:226), interleukin-1(cid:226).
`
`10.1021/bi991518m CCC: $19.00 © 2000 American Chemical Society
`Published on Web 12/28/1999
`
`Amgen Exhibit 2048
`Apotex Inc. et al. v. Amgen Inc. et al., IPR2016-01542
`Page 1
`
`

`

`576 Biochemistry, Vol. 39, No. 3, 2000
`
`Finke et al.
`
`a flow rate of 3 mL/min. Purity was judged to be greater
`than 95% as assessed by SDS-PAGE. Protein concentrations
`were calculated by using an experimentally determined (cid:15)280
`) 11.26 mM-1 cm-1 (21). Mass spectral analysis and DNA
`sequencing identified the mutant IL-1(cid:226) as a K97I variant,
`and not K97V as it had been previously reported (4). Purified
`protein was dialyzed extensively into 10 mM MES buffer
`containing 2 mM EDTA, 90 mM NaCl, and 1 mM (cid:226)me at
`pH 6.5 for all experiments discussed.
`Equilibrium Fluorescence. Equilibrium unfolding titrations
`were measured by use of intrinsic tryptophan fluorescence
`emission intensity (22, 23). Protein samples were diluted to
`varying final denaturant concentrations and equilibrated
`overnight. Protein concentrations ranged from 6 to 18 (cid:237)M
`in separate experiments. Fluorescence spectra were acquired
`on a Fluoromax-2 spectrofluorometer (SPEX, Edison, NJ).
`Fluorescence emission was measured as total intensity over
`the 300-450 nm emission range after excitation at 293 nm.
`Manual-Mixing Fluorescence. Unfolding experiments were
`initiated by addition of native IL-1(cid:226) stock into a cuvette to
`final GdnHCl concentrations ranging from 2 to 5 M and final
`IL-1(cid:226) concentrations ranging from 6 to 24 (cid:237)M. Refolding
`experiments were initiated by dilution of unfolded IL-1(cid:226) at
`2.2 M GdnHCl to final GdnHCl concentrations ranging from
`0.2 to 1.4 M and final IL-1(cid:226) concentrations ranging from 6
`to 36 (cid:237)M. The kinetics of folding reactions with relaxation
`times greater than 10 s were measured by the time-dependent
`change in fluorescence emission at 343 nm (slit 1 mm) while
`excitation was at 293 nm (slit 1 mm) with a Fluoromax-2
`spectrofluorometer equipped with a Neslab RTE-111 tem-
`perature controller.
`Stopped-Flow Fluorescence. Folding reactions with re-
`laxation times less than 10 s were monitored with an Applied
`Photophysics SX.17MV (Applied Photophysics, London)
`stopped-flow unit with a path length of 0.1 cm. Refolding
`experiments were initiated by a 1:10 dilution of unfolded
`IL-1(cid:226) at 2.2 M GdnHCl, except where indicated, into varying
`final IL-1(cid:226) concentrations and final GdnHCl concentrations.
`Unfolding experiments used 1:1 ratio mixing sizes such that
`1 part native IL-1(cid:226) dilutes into 1 part GdnHCl buffer.
`Excitation was at 293 nm and emission was collected through
`a >320 nm cutoff filter. Each kinetic trace is the average of
`10-20 data acquisitions.
`Interrupted Refolding Experiments. The reverse double-
`jump experiment (24)
`
`step 1
`unfolded 98
`(ti)
`
`step 2
`folded 98
`
`unfolded
`
`was performed to measure the time-dependent production
`of native wild-type and K97I protein. Folding (step 1) was
`initiated by diluting 4 parts unfolded protein in 3.0 M
`GdnHCl with 9 parts buffer to reach a final buffer concentra-
`tion of 0.8 M GdnHCl. After various times (ti), refolding
`was interrupted by transferring the solution into a final
`GdnHCl concentration of 4.5 M (step 2). Partially folded
`intermediates present
`immediately prior to step 2 are
`extremely unstable (0.8 M GdnHCl refolding conditions),
`unfold quickly during step 2, and are therefore not measured.
`However, under these conditions, the population of native
`IL-1(cid:226) unfolds at the expected rate ((cid:244)step2 (cid:24) 400 s). Conse-
`quently, native IL-1(cid:226) at each time point ti can be reliably
`
`FIGURE 1: MOLMOL representation (44) of the solution structure
`of human interleukin 1(cid:226) (45) down the (cid:226)-barrel with secondary
`structure elements as defined by Kabsch and Sander (46). Residues
`demonstrating early amide-proton protection are shown as dark
`strands. Residues demonstrating late amide-proton protection are
`shown as light strands. The residue 86-99 loop microdomain is
`indicated and the extended side chain of lysine 97 is shown.
`
`K97I inclusion bodies in vivo and aggregates in vitro contain
`a significant and similar degree of secondary structure, yet
`both are different from the native state (19).
`We now report the results of manual-mixing and stopped-
`flow optical experiments on the folding reaction of WT and
`K97I at pH 6.5 and 25 (cid:176) C. Using kinetic analyses of both
`folding and aggregation, we have determined that K97I self-
`associates when unfolded conformers predominate and that
`formation of stable folding intermediates protects against
`further association. We have proposed structural details of
`the initial aggregation stage and how aggregation is subse-
`quently prevented during the folding process, a prerequisite
`to any further studies of the final insoluble aggregates.
`
`MATERIALS AND METHODS
`Expression and Purification of IL-1(cid:226) and K97I. The gene
`encoding either wild-type IL-1(cid:226) (WT) or the K97I sequence
`variant were subcloned into a pET 24-d vector (Novagen)
`and transformed into E. coli BL21(DE3) cells. Cells were
`grown in LB to an OD600 of 0.8 and protein expression was
`induced with IPTG at a final concentration of 1 mM.
`Rifampicin was added 45 min after induction to a final
`concentration of 0.1 mg/mL. Three hours after induction,
`cells were harvested by centrifugation at 10000g for 30 min.
`Purification of IL-1(cid:226) was based on the procedure of
`Meyers et al. (20) but with a number of modifications. Cells
`were resuspended in 10 mM KPO4, 0.2 mM EDTA, 5 mM
`DTT, and 1 mM PMSF at pH 8.0 and then lysed by
`sonication at 4 (cid:176) C, followed by centrifugation at 4300g for
`30 min. Soluble IL-1(cid:226) in the supernatant was made 80%
`saturated in ammonium sulfate and then precipitated by
`centrifugation as above. The pellet was then dissolved in
`buffer A (25 mM NH4OAc, 2 mM EDTA, and 1 mM (cid:226)me
`at pH 4.5) and dialyzed overnight in buffer A at 4 (cid:176) C.
`The dialysate was centrifuged as above, filtered, and
`applied to a Resource S cation-exchange column (Pharmacia)
`equilibrated in buffer A. IL-1(cid:226) was eluted in a 40 column
`volume linear gradient of 25-240 mM NH4OAc, pH 4.5, at
`
`Page 2
`
`

`

`Aggregation of Interleukin 1(cid:226)
`
`Biochemistry, Vol. 39, No. 3, 2000 577
`
`quantitated by the amplitude of the resulting unfolding kinetic
`exponential (cid:244)step2. All amplitudes were normalized to the
`amplitude recovered from step 2 on 100% native protein.
`No amplitude was observed when unfolded IL-1(cid:226) (3.0 M
`GdnHCl) was diluted into the final conditions (4.5 M
`GdnHCl), confirming that measured amplitudes could result
`only from native IL-1(cid:226) formed from folding after step 1 and
`not from extraneous processes. Spectroscopic conditions were
`as described under Manual-Mixing Fluorescence.
`Stopped-Flow Light Scattering. Protein aggregation during
`refolding was monitored with an Applied Photophysics
`SX.17MV (Applied Photophysics, London) stopped-flow unit
`with a path length of 0.1 cm. Aggregation was initiated by
`a 1:10 dilution of IL-1(cid:226) from 2.2 M GdnHCl (except where
`noted) to the indicated final IL-1(cid:226) concentrations of protein
`and final GdnHCl concentrations. Aggregation was measured
`by light scattering at a wavelength of 500 nm and collected
`at a 90(cid:176) angle through a >320 nm cutoff filter. Each kinetic
`trace is the average of 10-20 data acquisitions.
`Fraction Aggregated. Refolding experiments were initiated
`by a 1:10 dilution of IL-1(cid:226) from 2.2 M GdnHCl, except
`where noted, to the indicated final IL-1(cid:226) concentrations of
`protein and 0.4 M GdnHCl. Samples were centrifuged at
`7000g and the completeness of the aggregate separation was
`assessed by the absence of turbidity at 500 nm. The dissolved
`protein concentration was measured by the absorbance at
`280 nm and calculated by use of the extinction coefficient
`(cid:15)280 ) 11.26 mM-1 cm-1 and the Beer-Lambert relationship
`(21).
`Data Analysis. Equilibrium data were fit as described
`previously (4). Manual mixing kinetics, stopped-flow kinet-
`ics, and interrupted refolding data were fit globally (25) to
`eq 1 using the Marquardt algorithm (26) and in-house
`software:
`
`i
`
`A(t) ) (cid:229)
`
`Ai exp(-t/(cid:244)i) + A(¥
`
`)
`
`(1)
`
`The number of kinetic processes i, relaxation time (cid:244)i, signal
`amplitude Ai of each exponential kinetic process i, and the
`final signal value A(¥
`) at equilibrium were determined using
`the fit quality represented in the chi-squared (ł
`2) values (27),
`r
`the random dispersion of residuals, and the logical consis-
`tency of the generated fitting parameters. The relaxation time
`(cid:244) equals the inverse of the observed rate constant (i.e., 1/kobs)
`and does not directly measure the microscopic rate constant
`for a kinetic process (28).
`
`RESULTS
`
`Equilibrium Fluorescence. The equilibrium transition for
`K97I IL-1(cid:226) is shifted to higher denaturant concentrations,
`consistent with a 0.9 kcal/mol increase in thermodynamic
`stability of the native protein with mutation, as observed
`previously (16, 18, 22).
`Fluorescence Measured Kinetics. A plot of the change in
`fluorescence intensity above 320 nm as a function of time
`for a stopped-flow refolding jump of WT IL-1(cid:226) from 2.2 to
`0.2 M GdnHCl is given in Figure 2A. The first 20 s of the
`reaction are shown for clarity. The initial
`increase in
`fluorescence intensity is characterized by two exponential
`processes and is followed by a slow process in which the
`decay in fluorescence intensity approaches the expected
`
`FIGURE 2: Real-time kinetic fluorescence measurements during the
`refolding of WT IL-1(cid:226). (A) Refolding from 2.2 to 0.2 M GdnHCl
`by stopped-flow mixing. Individual data points ((cid:226)) are shown along
`with the 3-exponential fit (s). (Inset) Residuals of the kinetics fit
`to three exponential processes (cid:244)1, (cid:244)2, and (cid:244)3. (B) Refolding from
`2.2 to 0.2 M GdnHCl by manual mixing. Under these conditions,
`the displayed (cid:244)1 process is characterized by a decrease in fluores-
`cence with time. (C) Refolding from 2.2 to 1.0 M GdnHCl by
`manual mixing. Under these conditions, the displayed (cid:244)1 process
`is characterized by an increase in fluorescence with time. Given
`the change in sign for the amplitude of (cid:244)1 between panels B and C,
`interpretation of amplitude changes over GdnHCl concentrations
`for the three kinetic processes (cid:244)1, (cid:244)2, and (cid:244)3 will be ambiguous.
`
`equilibrium value. This nonmonotonic change in fluorescence
`intensity as a function of time measures the population of a
`highly fluorescent intermediate formed prior to the native
`protein and is consistent with the finding of a populated
`intermediate with pulse-labeling techniques (1, 2). The
`calculated fit of the data to a three-exponential process is
`shown for comparison (Figure 2A). The plot of the residual
`errors for the fit of the data to a three-exponential equation
`is given in the inset to Figure 2A. As demonstrated in Figure
`2 panels B (0.2 M GdnHCl) and C (1.0 M GdnHCl), the
`slowest process has either a negative (Figure 2B) or positive
`(Figure 2C) fluorescence amplitude, depending upon the final
`denaturant concentration in the refolding jumps. This ob-
`servation is consistent with the changes in equilibrium
`fluorescence measurements of the native state observed at
`0.2 and 1.0 M GdnHCl, respectively. Global analysis of both
`WT and K97I refolding data consistently fit best to three
`exponential processes and are designated as (cid:244)3 (fast), (cid:244)2
`(medium), and (cid:244)1 (slow). Analysis of both WT and K97I
`unfolding data under all conditions consistently fit best to
`one exponential process and is designated (cid:244)1(slow). The two
`faster processes observed in the refolding reactions, (cid:244)3 and
`(cid:244)2, were not observed in unfolding by either manual-mixing
`or stopped-flow techniques (data not shown).
`
`Page 3
`
`

`

`578 Biochemistry, Vol. 39, No. 3, 2000
`
`Finke et al.
`
`FIGURE 3: Manual mixing kinetic fluorescence measurement of
`folding and unfolding kinetic parameters for WT A1/(cid:244)1 refolding
`(O), WT A1/(cid:244)1 unfolding (b), K97I A1/(cid:244)1 refolding (]), and K97I
`A1/(cid:244)1 unfolding ([). (A) Amplitude A1 of (cid:244)1 folding/unfolding
`process with respect to final GdnHCl concentration. (B) Relaxation
`time of (cid:244)1 folding/unfolding process with respect to final GdnHCl
`concentration. The values of (cid:244)1 are essentially identical for WT
`and K97I, as observed previously (17).
`
`Fluorescence-detected folding kinetics for both WT and
`K97I were performed over a series of denaturant concentra-
`tions and 18 (cid:237)M protein. The observed amplitude A1 and
`slow relaxation time (cid:244)1, determined in manual-mixing
`experiments as a function of final denaturant concentration,
`are given in Figure 3. The refolding relaxation time (cid:244)1 varies
`from 30 s under strongly refolding conditions (0.2 M
`GdnHCl) to 1900 s in the transition region (1.0 M GdnHCl),
`where solution conditions support the formation of a highly
`fluorescent nativelike species (18). Unfolding relaxation
`times vary from 160 s under strongly unfolding conditions
`(5 M GdnHCl) to 3100 s in the transition region (2 M
`GdnHCl). Neither the observed relaxation times nor the
`fluorescence amplitudes for the slow (cid:244)1 process differ
`appreciably between the WT and K97I mutant proteins,
`consistent with previously published observations (16).
`In stopped-flow fluorescence experiments, an initial
`increase in fluorescence intensity observed in refolding
`experiments at 18 (cid:237)M protein is described by two exponential
`process, (cid:244)3 and (cid:244)2. Interpretation of the GdnHCl dependence
`of the amplitudes of (cid:244)3 and (cid:244)2, A3 and A2, is unreliable
`because the amplitude A1 changes from negative to positive
`at increasing GdnHCl concentrations (Figure 2A) and affects
`the fitted values of A3, A2, and A1. Therefore, a qualitative
`analysis of fluorescence amplitudes follows. The observed
`amplitudes A3 and A2 for both the WT and K97I protein are
`shown as a function of final denaturant concentration in
`Figure 4A. The major difference in amplitudes of the fast
`processes between WT and K97I is in A2. K97I A2 is much
`
`FIGURE 4: Stopped-flow kinetic fluorescence measurements for
`refolding kinetic parameters WT A3/(cid:244)3 (0), WT A2/(cid:244)2 ("), K97I
`A3/(cid:244)3 (4), and K97I A2/(cid:244)2 (3). Error bars represent 95% confidence
`intervals. WT and K97I A3/(cid:244)3 are not shown above 1.0 M GdnHCl
`because the amplitude A3 can no longer be resolved. (A) Amplitude
`(in PMT volts) of kinetic folding processes WT A3, WT A2, K97I
`A3, and K97I A2. (B) Relaxation time of WT (cid:244)3, WT (cid:244)2, K97I (cid:244)3,
`and K97I (cid:244)2 folding processes with respect
`to final GdnHCl
`concentration. The values of K97I (cid:244)2 do not follow simple
`denaturant concentration dependence.
`
`lower than WT A2 at 0.2 M GdnHCl but increases to the
`value of the WT A2 at 0.8 M GdnHCl and behaves similarly
`to WT at higher GdnHCl concentrations. Although a
`quantitative interpretation of the amplitudes is precluded (see
`above), it is nonetheless clear that the major amplitude
`differences between K97I and WT occur in A2.
`In Figure 4B, the WT relaxation times (cid:244)3 and (cid:244)2 at 18 (cid:237)M
`protein display the characteristic denaturant concentration
`dependence expected for a protein folding reaction (29). K97I
`(cid:244)3 is slightly accelerated with respect to WT (cid:244)3 and increases
`logarithmically from 50 ms at 0.2 M GdnHCl to 780 ms at
`1.0 M GdnHCl. In contrast, K97I (cid:244)2 displays kinetic behavior
`that does not follow simple denaturant concentration depen-
`dence. K97I (cid:244)2 displays a relaxation time of approximately
`1 s, which is independent of GdnHCl concentrations below
`0.6 M, as opposed to WT (cid:244)2, which decreases to 260 ms at
`0.2 M GdnHCl. Repeated experiments (4(cid:2)) with different
`protein preparations demonstrate that differences between
`WT and K97I are reproducible and statistically significant,
`as shown by 95% confidence intervals in Figure 4. Above
`0.6 M GdnHCl, K97I (cid:244)2 is denaturant-dependent and similar
`in rate to WT (cid:244)2. For both WT and K97I above 1.0 M
`GdnHCl, the (cid:244)3 process is no longer observable and (cid:244)2
`reaches a maximum near 4 s.
`Interrupted Refolding Experiments. At pH 5.0, the fast
`processes in the refolding reaction of the WT protein are
`not a result of parallel paths to the native protein (2). To
`
`Page 4
`
`

`

`Aggregation of Interleukin 1(cid:226)
`
`Biochemistry, Vol. 39, No. 3, 2000 579
`
`test whether native WT and K97I also accumulate from a
`single folding route at pH 6.5, we performed interrupted
`refolding experiments (24). The time-dependent recoveries
`of the native-state amplitude during step 2 of the interrupted
`folding experiment (see Materials and Methods) for both WT
`and K97I are each accurately fit to a single-exponential
`process. The relaxation time for this process is 420 s for the
`WT and 370 s for K97I (data not shown), consistent with
`the slowest refolding process (cid:244)1, as seen in Figure 3B. If a
`fast refolding process ((cid:244)3 or (cid:244)2) also led to native protein
`production, a significant amount of native-state amplitude
`would be observed during step 2 at the earliest time point (ti
`) 10 s), which is not the case here.
`Variation of Initial Denaturant Concentrations. To address
`whether residual structure in the unfolded state under high
`denaturant concentration is responsible for the observed
`differences in the (cid:244)2 process for the WT and K97I proteins,
`a series of experiments were performed at 18 (cid:237)M protein in
`which the initial GdnHCl concentrations in the refolding
`reactions were varied. The amplitudes and relaxation times
`for the refolding processes for both WT and K97I are
`independent of the initial unfolding conditions.
`Aggregation. The final protein concentration in refolding
`was varied to determine whether protein association could
`account for the observed differences in the A2 amplitude and
`the (cid:244)2 relaxation time at 0.4 M final GdnHCl for K97I as
`compared to WT (Figure 4). We observed protein association
`during K97I refolding by two detection methods:
`(1)
`fluorescence at 293 nm excitation, 320-400 nm emission,
`and (2) light scattering at 500 nm.
`When the refolding relaxation times (cid:244)3 and (cid:244)2 of WT and
`K97I are observed by stopped-flow fluorescence with 0.4
`M final GdnHCl, only the (cid:244)2 process of K97I is dependent
`on protein concentration (Figure 5). The (cid:244)2 rate decreases
`2-fold and the normalized amplitude A2 (PMT volts/(cid:237)M)
`decreases 40% as the protein concentration is increased from
`3 to 42 (cid:237)M.
`Protein association during refolding in 0.4 M final GdnHCl
`was followed more directly by stopped-flow light scattering
`at 500 nm. A plot of the signal change at 500 nm as a
`function of refolding time for WT and K97I is given in
`Figure 6. As IL-1(cid:226) contains no chromophores that either
`absorb or emit light at this wavelength, any observed signal
`change can be attributed to particulate formation as a result
`of protein aggregation. Over the range of protein concentra-
`tions measured, 3-48 (cid:237)M, WT did not show any appreciable
`increase in light scattering. At 18 (cid:237)M K97I, there is no
`measurable change in the optical signal with time. However,
`at higher protein concentrations, K97I displays measurable
`light scattering occurring within the first seconds of acquisi-
`tion.
`Light scattering behavior during refolding was also studied
`while first varying the initial GdnHCl concentration (Figure
`7A) and then varying the final GdnHCl concentration (Figure
`7B) with a constant protein concentration of 0.55 mg/mL
`K97I. Variations in the initial GdnHCl did not affect the
`light scattering behavior of K97I at either 0.4 or 0.6 M final
`GdnHCl (Figure 7A). This is consistent with the indepen-
`dence of the folding process to initial unfolding conditions
`as monitored by fluorescence (see above). However, increas-
`ing the final GdnHCl concentration in the refolding process
`
`FIGURE 5: Effect of increasing protein concentration from 3 to 48
`(cid:237)M on measured folding parameters WT A3/(cid:244)3 (0), WT A2/(cid:244)2 ("),
`K97I A3/(cid:244)3 (4), and K97I A2/(cid:244)2 (3). (A) Amplitudes A3 and A2 of
`respective kinetic processes (cid:244)3 and (cid:244)2 measured during the refolding
`of WT and K97I at 3-48 (cid:237)M protein. (B) Refolding relaxation
`times (cid:244)3 and (cid:244)2 measured during the refolding of WT and K97I at
`3-48 (cid:237)M protein. K97I amplitude A2 decreases 2-fold and K97I
`relaxation time (cid:244)2 increases 2-fold as concentration is increased,
`indicating an association process during K97I refolding not present
`in WT refolding.
`
`FIGURE 6: Stopped-flow light scattering behavior during refolding
`of WT and K97I at increasing protein concentrations from 3 to 48
`(cid:237)M. (Left panel) Time dependence of light scattering in WT
`refolding versus protein concentration. (Right panel) Time depen-
`dence of light scattering in K97I refolding versus protein concentra-
`tion. Both panels A and B are represented on the same scale. At a
`final GdnHCl concentration of 0.4 M GdnHCl and protein
`concentrations >18 (cid:237)M, K97I exhibits light scattering behavior
`consistent with aggregation.
`
`demonstrated a reduction in the light scattering amplitude,
`which is due to a drop in aggregation (Figure 7B).
`
`Page 5
`
`

`

`580 Biochemistry, Vol. 39, No. 3, 2000
`
`Finke et al.
`
`FIGURE 9: Analysis of stopped-flow light scattering data during
`refolding of K97I to 0.4 M GdnHCl and 42 (cid:237)M K97I: Light
`scattering intensity in volts over 0-2 s after mixing and time
`derivative of light scattering in ¢volts/¢time over 0-2 s after
`mixing where ¢time interval ) (0.005 s. The decrease of the time
`derivative, taken together with the observed folding rates, supports
`a model in which aggregation takes place before stable IL-1(cid:226)
`structure formation.
`
`K97I concentration. The percent of K97I aggregation at any
`final protein concentration in Figure 8 has been shown to
`be independent of the initial concentration of unfolded protein
`prior to dilution and refolding (data not shown).
`
`DISCUSSION
`
`Protein aggregation is a problem in the recovery of
`bioactive recombinant proteins and may also lead to patho-
`logical conditions in vivo and in vitro. Although many
`proteins aggregate under native conditions, it may be that
`pathological or recombinant protein aggregation reactions
`are mediated through association of a nonnative species (7,
`11, 12, 19, 30-38). If nonnative states are responsible for
`aggregation, it is essential that they be characterized. In the
`current study, we performed kinetic experiments under
`conditions where folding and aggregation compete to gain a
`better understanding of these processes.
`Aggregation Occurs Prior to Stable Intermediate Forma-
`tion. At elevated protein concentrations the mutation of K97
`to isoleucine affects early events in the folding reaction of
`IL-1(cid:226) (Figures 4 and 5), particularly the (cid:244)2 folding process
`and the extent of self-association. With regard to increasing
`protein concentration, the correlation between the lowered
`amplitude and rate of the (cid:244)2 refolding process (Figure 5) and
`the increasing amplitude of light scattering (Figure 6)
`indicates that folding and aggregation are competing pro-
`cesses in K97I.
`Figure 9 shows the intensity of light scattering and its time
`derivative plotted as a function of time. The time derivative
`of the observed light scattering signal is directly proportional
`to the concentration and the square of the molecular weight
`of the species involved in aggregation (39). The aggregation
`rate should be maximal under conditions where the aggregat-
`ing species is most highly populated, as the aggregation
`reaction is at least second-order in the concentration depen-
`dence. The time derivative of the light scattering intensity
`is dependent on the aggregation rate, and consequently the
`concentration of the associating species. Therefore, if ag-
`
`FIGURE 7: Effect of initial and final GdnHCl concentration during
`refolding of K97I on stopped-flow light scattering behavior. (A)
`Light scattering at initial GdnHCl concentrations 2.2, 3.0, and 4.0
`M and final concentrations 0.4 and 0.6 M. (B) Light scattering at
`an initial GdnHCl concentration of 2.2 M and final concentrations
`0.4, 0.6, 0.8, and 1.0 M. Initial GdnHCl concentration does not
`affect the extent of aggregation, while increasing the final GdnHCl
`decreases aggregation.
`
`FIGURE 8: Fraction of K97I aggregated in post-refolding equilib-
`rium relative to soluble K97I as a function of the total concentration
`of K97I. The fraction of aggregated K97I was determined quan-
`titatively through UV absorbance at 280 nm of the dissolved protein
`(O) and qualitatively through solution turbidity at 500 nm (b). The
`relatively low fraction of K97I aggregate (<50%) during refolding
`experiments supports an aggregation model mediated by an early,
`transiently populated species.
`
`Aggregation was quantified by measuring the fraction of
`K97I found in the dissolved and precipitated fractions after
`the completion of folding at 0.4 M final GdnHCl. The
`percentage of protein found in the precipitated fraction was
`assayed by the observed sample turbidity at 500 nm and by
`quantitating the amount of protein remaining in the soluble
`portion (Figure 8). There is good agreement between the two
`sets of data, which indicates a cooperative transition between
`the soluble and insoluble percentage as a function of total
`
`Page 6
`
`

`

`Aggregation of Interleukin 1(cid:226)
`
`Biochemistry, Vol. 39, No. 3, 2000 581
`
`gregation occurs when the unfolded populations predominate,
`the time derivative is expected to start from its maximum
`value and subsequently fall as the species depopulates. If an
`intermediate (I) aggregates, the time derivative is expected
`to rise and fall in concert with the transient population of
`this species. If the native state (N) aggregates, the time
`derivative should initially be zero and increase with a rate
`reflecting the population of the native protein.
`By use of the measured folding rates (Figure 4A) and the
`light scattering data (Figure 6) at 42 (cid:237)M K97I and 0.4 M
`GdnHCl, the most probable aggregating species can be
`identified. The light scattering time derivative falls from an
`initial maximal value to nearly zero at 2 s after the initiation
`of folding (Figure 9). This same result is found at all protein
`and GdnHCl concentrations investigated. Consequently, the
`species whose predicted aggregation explains these observa-
`tions is the unfolded ensemble U. The aggregation of U is
`also supported by the observation that refolding at 0.4 M
`GdnHCl and 42 (cid:237)M K97I produces a relatively low fraction
`(<50%) of aggregated protein (Figure 8), since

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket